Search
15 studies match these filters. Showing 1–15 of 15 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT06283966 | A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 921 sites in total | Recruiting | Phase 3 | 5,000target | 921 / 37 | 2024 | Aug 26, 2026 | |
| NCT06932263 | Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids. ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 221 sites in total | Recruiting | Phase 2 | 540target | 221 / 21 | 2025 | Jul 20, 2026 | |
| NCT05655182 | A Study of BLB-201 RSV Vaccine in Infants and Children This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 m… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 16 sites in total · contact listed | Recruiting | Phase 1 / Phase 2 | 137target | 16 / 1 | 2023 | Jul 29, 2026 | |
| NCT06122077 | Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants who will undergo a routine, standard-of-care screening Low-Dose Computed Tomography (LDCT). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 36 sites in total · contact listed | Recruiting | 20,000target | 36 / 1 | 2023 | Aug 5, 2025 | ||
| NCT03851445 | Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will deter… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 1,229 sites in total | Recruiting | Phase 2 / Phase 3 | 10,000target | 1,229 / 1 | 2019 | May 18, 2026 | |
| NCT04613596 | Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study com… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 770 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 626target | 770 / 47 | 2020 | Sep 16, 2026 | |
| NCT04181060 | Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 603 sites in total · contact listed | Recruiting | Phase 3 | 300target | 603 / 1 | 2020 | Sep 10, 2026 | |
| NCT07213778 | REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 36 sites in total | Recruiting | Phase 3 | 2,000target | 36 / 4 | 2025 | Sep 14, 2026 | |
| NCT04267848 | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immun… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 1,151 sites in total | Recruiting | Phase 3 | 1,210target | 1,151 / 2 | 2020 | Sep 8, 2026 | |
| NCT06561386 | A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1% ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 326 sites in total · contact listed | Recruiting | Phase 3 | 1,000target | 326 / 31 | 2024 | Sep 14, 2026 | |
| NCT05624996 | Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by immunotherapy with durvalumab or targeted therapy with osimertinib) versus the usual treatment alone… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 477 sites in total · contact listed | Recruiting | Phase 3 | 474target | 477 / 2 | 2023 | Aug 17, 2026 | |
| NCT07779408 | Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above. The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose levels (low, medium, and high dose) given with or without adjuvant to see if the adjuvant improves vaccine effectiveness. The study will enroll healthy adults aged 18 years and over. Participants will receive 2 injections i… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 16 sites in total | Recruiting | Phase 1 / Phase 2 | 640target | 16 / 1 | 2026 | Sep 15, 2026 | |
| NCT07629440 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumoco… ✓ Contact✗ Claimed Nearest site: Derby, Kansas, United States — 54 km away · 124 sites in total | Recruiting | Phase 3 | 3,230target | 124 / 3 | 2026 | Sep 8, 2026 | |
| NCT07415031 | A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorect… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 100 sites in total · contact listed | Recruiting | Phase 2 | 170target | 100 / 20 | 2026 | Aug 18, 2026 | |
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 745 sites in total · contact listed | Recruiting | 2,000target | 745 / 1 | 2022 | Sep 2, 2026 |